Camila dos Santos Chagas
Camila dos Santos Chagas has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Emerson Barbosa da Silva
Centro Universitário FMABC
2 shared publications Alexandre L. A. Fonseca
Laboratório de Análises Clínicas da Faculdade de Medicina Do ABC, Santo André, São Paulo, Brazil
1 shared publication- Ariane de Espindola1 shared publication
Beatriz da C. A. Alves
Laboratório de Análises Clínicas da Faculdade de Medicina Do ABC, Santo André, São Paulo, Brazil
1 shared publication- Bruna Giovana de Souza Silva
Centro Universitário FMABC
1 shared publication David Feder
Laboratório de Análises Clínicas da Faculdade de Medicina Do ABC, Santo André, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 November 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (11)
Metabolic evaluation of brain tumors by proton magnetic resonance spectroscopy (¹H-MRS): Comparative analysis between 1.5T and 3T Systems
Introduction: Proton magnetic resonance spectroscopy (¹H-MRS) is a noninvasive tool of great relevance for detecting metabolites in brain tumors, allowing the early identification of biochemical alterations before morphological changes appear in conventional imaging. However, technical factors such as magnetic field strength and differences between equipment manufacturers may affect diagnostic accuracy. Objectives: To analyze the main metabolic findings obtained through ¹H-MRS in brain tumors and to compare the performance of different manufacturers (Siemens, GE, and Philips) operating at 1.5T and 3T magnetic fields, focusing on diagnostic sensitivity. Method: A systematic review was conducted according to PRISMA guidelines. Studies published in the last ten years in MEDLINE/PubMed databases that applied ¹H-MRS for brain tumor assessment were included, focusing on the detection of metabolites such as N-acetyl aspartate (NAA), choline (Cho), creatine (Cr), lactate (Lac), and myo-inositol (Mi). A total of 33 articles met the eligibility criteria. Results: Magnetic field strength had a greater impact on spectral quality than manufacturer differences. 3T systems demonstrated superior spectral resolution, higher signal-to-noise ratio, and greater ability to detect low-concentration metabolites such as Mi and Lac. Metabolic ratios (NAA/Cr and Cho/Cr) were more accurate at 3T. Variations among Siemens, GE, and Philips systems were minimal and clinically insignificant. Conclusion: ¹H-MRS is a valuable technique for metabolic evaluation, aiding in the diagnosis and monitoring of brain tumors. Higher magnetic fields (3T) provide improved sensitivity and specificity, and protocol standardization is essential for multicenter studies.
- 1 November 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (11)
Open AccessMetabolic evaluation of brain tumors by proton magnetic resonance spectroscopy (¹H-MRS): Comparative analysis between 1.5T and 3T Systems
Introduction: Proton magnetic resonance spectroscopy (¹H-MRS) is a noninvasive tool of great relevance for detecting metabolites in brain tumors, allowing the early identification of biochemical alterations before morphological changes appear in conventional imaging. However, technical factors such as magnetic field strength and differences between equipment manufacturers may affect diagnostic accuracy. Objectives: To analyze the main metabolic findings obtained through ¹H-MRS in brain tumors and to compare the performance of different manufacturers (Siemens, GE, and Philips) operating at 1.5T and 3T magnetic fields, focusing on diagnostic sensitivity. Method: A systematic review was conducted according to PRISMA guidelines. Studies published in the last ten years in MEDLINE/PubMed databases that applied ¹H-MRS for brain tumor assessment were included, focusing on the detection of metabolites such as N-acetyl aspartate (NAA), choline (Cho), creatine (Cr), lactate (Lac), and myo-inositol (Mi). A total of 33 articles met the eligibility criteria. Results: Magnetic field strength had a greater impact on spectral quality than manufacturer differences. 3T systems demonstrated superior spectral resolution, higher signal-to-noise ratio, and greater ability to detect low-concentration metabolites such as Mi and Lac. Metabolic ratios (NAA/Cr and Cho/Cr) were more accurate at 3T. Variations among Siemens, GE, and Philips systems were minimal and clinically insignificant. Conclusion: ¹H-MRS is a valuable technique for metabolic evaluation, aiding in the diagnosis and monitoring of brain tumors. Higher magnetic fields (3T) provide improved sensitivity and specificity, and protocol standardization is essential for multicenter studies.
- Open Access
- 30 May 2024
- Published by Elsevier in Next Nanotechnology
- Vol. 6
Antioxidant action of L-cysteine anchored on the surface of magnetite nanoparticles
- 30 May 2024
- Published by Elsevier in Next Nanotechnology
- Vol. 6
Open AccessAntioxidant action of L-cysteine anchored on the surface of magnetite nanoparticles
- Open Access
- 1 January 2019
- Published by Wolters Kluwer Health in European Journal of Oncology Pharmacy
- Vol. 2 (1) , e9
Synadenium umbellatum and the Ehrlich's solid tumor treatment
Introduction: Studies have been attributed to cancer treatment, including the potential of several plants with putative anticancer activity. Among these is “Cola-note” (Synadenium umbellatum). Methods: We evaluated the effects of macerated S umbellatum at a concentration of 10 mg/kg in Bagg albino strain c mice and its myelotoxic, hepatotoxic, and antitumor activity as well as the expression of inflammatory genes (TGF-β1 and TNF-α). Cells from Ehrlich tumor were implanted in the dorsolateral region of 8 mice of the Bagg albino strain c mice; these animals were divided into control (treated with NaCl 0.9%) and treatment group (treated with macerated Cola-Nota 10 mg/kg). Results: Treatment group animals showed no hepatotoxicity, but a potential myelotoxicity. The results suggest that treatment with Cola-Note macerate causes a decrease in expression of TNF-α and an increased expression of TGF-β1. Discussion: The S umbellatum (10 mg/kg) is shown to be effective in reducing the concentration of neoplastic cachexia, but there was no antitumor activity.
- 1 January 2019
- Published by Wolters Kluwer Health in European Journal of Oncology Pharmacy
- Vol. 2 (1) , e9
Open AccessSynadenium umbellatum and the Ehrlich's solid tumor treatment
Introduction: Studies have been attributed to cancer treatment, including the potential of several plants with putative anticancer activity. Among these is “Cola-note” (Synadenium umbellatum). Methods: We evaluated the effects of macerated S umbellatum at a concentration of 10 mg/kg in Bagg albino strain c mice and its myelotoxic, hepatotoxic, and antitumor activity as well as the expression of inflammatory genes (TGF-β1 and TNF-α). Cells from Ehrlich tumor were implanted in the dorsolateral region of 8 mice of the Bagg albino strain c mice; these animals were divided into control (treated with NaCl 0.9%) and treatment group (treated with macerated Cola-Nota 10 mg/kg). Results: Treatment group animals showed no hepatotoxicity, but a potential myelotoxicity. The results suggest that treatment with Cola-Note macerate causes a decrease in expression of TNF-α and an increased expression of TGF-β1. Discussion: The S umbellatum (10 mg/kg) is shown to be effective in reducing the concentration of neoplastic cachexia, but there was no antitumor activity.